Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ProJect Pharmaceutics Expands Safety Facilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

ProJect Pharmaceutics Expands Safety Facilities

Adds labs dedicated to handle GMO S2 and BSL-2 based biologic products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ProJect Pharmaceutics (PJP), a company specializing in formulation and process development for parenteral drug products, has extended its safety facilities with laboratories dedicated to handle GMO S2 and BSL-2 based biologic products, such as live virus vaccines, protective and therapeutic vaccines, as well as gene and cell therapy products.

The GMO S2 and BSL-2 safety lab is equipped with a dedicated pilot freeze dryer to design tailored lyophilization cycles. Also, analytical high-throughput methods have been implemented in order to select the most effective combination of excipients for the final drug product to maintain the active quaternary structure of a virus capsid and avoiding aggregation, even under stress conditions like elevated temperature, freezing and freeze drying, according to the company.

PJP provides smart formulations and manufacturing processes for virus vaccines or other classified drug products in their dedicated labs in compliance with mandatory safety requirements up to GMO S2 and BSL-2 classification. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics